Skip to main content

Table 2 Description of SPAST gene variants identified in individuals with HSP.

From: Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements

Variant#

Identified by

Location

Predicted effect at the protein level#

Present in

(49 patients/

100 controls)

Patients

Intrafamilial segregation

Inferred

pathogeneity

c.131C>T*

S

exon 1

p.S44L

2/0

2942, 2943

-

NP

c.484G>A

DHPLC/S

exon 2

p.V162I

3/0

2627, 2747, 2943

-

NP

c.685A>G

DHPLC/S

exon 5

p.S229G

1/0

2930

-

NP

c.1174-1G>C

S

intron 8

missplicing (deletion

exon 9?)

3/0

2109, 2930, 2931

Yes

P

c.1185delA

DHPLC/S

exon 9

p.V385VfsX11

1/0

2752

-

P

c.1276 C>T

S

exon 10

p.L426F

3/0

2388, 2747, 2754

Yes

P

c.1245+202delG*

S

intron 10

none

3/4

2321, 2386, 2750

-

NP

c.1245+215G>C

S

intron 10

none

1/2

2960

-

NP

c.1352_1356del GAGAA

DHPLC/MLPA/S

exon 11

p.R451RfsX5

1/0

2753

-

P

c.1378C>A

DHPLC/S

exon 11

p.R460S

2/0

2480, 2482

Yes

P

c.1518_1519insTC

MLPA/S

exon 13

p.S507SfsX23

1/0

2478

-

P

c.1841_1842insA

DHPLC/S

exon17

p.T614NfsX

no Stop codon

1/0

2389

-

P

  1. #nomenclature according to HGVS http://www.hgvs.org/mutnomen/; *previously described; DHPLC - denaturing high performance liquid chromatography; MLPA - multiplex ligation-dependent probe amplification; S - sequencing; P - pathogenic; NP - non-pathogenic.